Pneumococcal Pneumonia in Hospitalized Uruguayan Children and Potential Prevention with Different Vaccine Formulations

Journal of Pediatrics

Volumn 152, Issue 6, 2008, Pages 850-853

  Hortal, María ^a   Sehabiague, Graciela ^b   Camou, Teresa ^c   Iraola, Inés ^a   Estevan, Miguel ^b   Pujadas, Mónica ^d  

^a Ministry of Public Health Uruguay   (Uruguay)

^b Children's Hospital   (Uruguay)

^c National Reference Laboratory   (Uruguay)

^d Montevideo Medical School   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEPHALOSPORIN DERIVATIVE; PENICILLIN G; PNEUMOCOCCUS VACCINE; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD ANALYSIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DRUG FORMULATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFANT; INFECTION PREVENTION; LOBAR PNEUMONIA; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MICROBIOLOGICAL EXAMINATION; PEDIATRIC HOSPITAL; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; URUGUAY; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; URUGUAY;

EID: 43549116633     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.11.008     Document Type: Article

References (21)

1. Black R.E., Morris S.S., and Bryce J. Where and why are 10 million children dying every year?. Lancet 361 (2003) 2226-2234
2. Hausdorff W., Feikin D.R., and Klugman K.P. Epidemiological differences among pneumococcal serotypes. Lancet 5 (2005) 83-93
3. Clinical and Laboratory Standards Institute. M 100-S16. Vol 26. Wayne, PA. 2006.
4. Ruocco G., Curto S., Savio M., Laurani H., and Frocht R. Impacto y expriencia de vacunación contra Haemophilus influenzae tipo b. Rev Panam Salud Pública 5 (1999) 197-198
5. Hortal M., Estevan M., Iraola I., and De Mucio B. A population-based assessment of the disease burden of consolidated pneumonia in hospitalized children under five years of age. Intern Infect Dis J 11 (2007) 273-277
6. Hortal M., Camou T., Palacio R., Perez-Gifoni G., and Di Fabio J.L. Vigilancia de las neumococcias del niño hospitalizado: su prevención específica (1994-2000). Rev Med Uruguay 18 (2002) 66-75
7. Minkovitz C.S., Hugart N., Strobino D., Scharfstein D., Grason H., Hou W., et al. A practice-based intervention to enhance quality of care in the first 3 years of life: the healthy stepts for young children program. JAMA 290 (2003) 3081-3091
8. Lagos R., Di Fabio J.L., Moenne K., Muñoz A., Wasserman J., and De Quadros C. Uso de la radiografía de tórax para la vigilancia de las neumonías bacterianas en niños latinoamericanos. Rev Panam Salud Pública 13 (2003) 294-302
9. Feikin D.R., and Klugman K.P. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis 35 (2002) 47-55
10. Scheifele D., Halperin S., Pelletier L., and Talbot J. Invasive pneumococcal infections in Canadian Children, 1991-1998: implications for new vaccination strategies. Clin Infect Dis 31 (2000) 58-64
11. Camou T., Palacio R., Di Fabio J.L., and Hortal M. Invasive pneumococcal disease in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulation. Vaccine 21 (2003) 2102-2105
12. Camou T., Hortal M., and Tomasz A. The apparent importation of penicillin-resistant capsular type 14 Spanish/French clone of Streptococcus pneumoniae into Uruguay in the early 1990s. Microb Drug Resist 4 (1998) 19-24
13. 5-19 in Latin America. J Clin Microbiol 40 (2002) 3942-3950
14. Brueggermann A.B., Peto T.E., Crook D.W., Butler J.C., Kristinsson K.G., and Spratt B.G. Temporal and geographical stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 190 (2004) 1203-1211
15. Whitney C.G. Can vaccines control resistance?. The example of pneumococcal conjugate vaccine. Infect Dis Clin Pract 4 (2006) S24-S30
16. Pirez M.C., Martínez O., Ferrari A.M., Naurac A., Montano A., Rubio I., et al. Standard case management of pneumonia in hospitalized children in Uruguay, 1997 to 1998. Pediat Infect Dis J 20 (2001) 283-289
17. Kertesz D.A., Di Fabio J.L., Brandileone C., Castañeda E., Echaniz-Avilés G., Heitman I., et al. Invasive Streptococcus pneumoniae infection in Latin American children: results of the Pan American Health Organization surveillance study. Clin Infect Dis 26 (1998) 1355-1361
18. Di Fabio J.L., Castañeda E., Agudelo C.I., De La Hoz F., Hortal M., Camou T., et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America: SIREVA Vigía Group 1993-1999. Pediatr Infect Dis J 20 (2001) 959-967
19. Hortal M., Camou T., Palacio R., Diabarboure H., and García A. Ten-year review of invasive pneumococcal diseases in children and adults from Uruguay: clinical spectrum, serotypes and antimicrobial resistance. Internat Infect Dis J 4 (1999) 91-95
20. Advisory Committee on Immunization Practices (ACIP). Prevention of pneumococcal diseases. MMWR Recomm. Rep 46 (1997) 1-24
21. Kempe A., Lowery E., Pearson K.A., Renfrew B.L., Jones J.S., Steiner J.F., et al. Immunization recall: Effectiveness and barriers to success in an urban teaching clinic. J Pediatr 139 (2001) 630-635